Serdar M Dursun, Hiram Joseph Wildgust, Paul Strickland, Guy M Goodwin, Leslie Citrome, and Mike Lean

The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness
J Psychopharmacol 2008 22: 3-5. [PDF] [References]  

Dora Kohen and Hiram Joseph Wildgust

The evolution of hyperprolactinaemia as an entity in psychiatric patients
J Psychopharmacol 2008 22: 6-11. [Abstract] [PDF] [References]  

Peter Fitzgerald and Timothy G Dinan

Prolactin and dopamine: What is the connection? A Review Article
J Psychopharmacol 2008 22: 12-19. [Abstract] [PDF] [References]  

Philip W. Harvey, David J. Everett, and Christopher J. Springall

Adverse effects of prolactin in rodents and humans: breast and prostate cancer
J Psychopharmacol 2008 22: 20-27. [Abstract] [PDF] [References]  

Richard IG Holt

Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists
J Psychopharmacol 2008 22: 28-37. [Abstract] [PDF] [References]  

M Kassim Javaid and Richard IG Holt

Understanding osteoporosis
J Psychopharmacol 2008 22: 38-45. [Abstract] [PDF] [References]  

Chris Bushe, Michael Shaw, and Robert C Peveler

A review of the association between antipsychotic use and hyperprolactinaemia
J Psychopharmacol 2008 22: 46-55. [Abstract] [PDF] [References]  

Chris Bushe, David Yeomans, Tamsin Floyd, and Shubulade M Smith

Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics
J Psychopharmacol 2008 22: 56-62. [Abstract] [PDF] [References]  

Shubulade M Smith

The impact of hyperprolactinaemia on sexual function in patients with psychosis
J Psychopharmacol 2008 22: 63-69. [Abstract] [PDF] [References]  

Veronica O'Keane

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia
J Psychopharmacol 2008 22: 70-75. [Abstract] [PDF] [References]  

Carmine M. Pariante

Pituitary volume in psychosis: the first review of the evidence
J Psychopharmacol 2008 22: 76-81. [Abstract] [PDF] [References]  

James Walters and Ian Jones

Clinical questions and uncertainty — prolactin measurement in patients with schizophrenia and bipolar disorder
J Psychopharmacol 2008 22: 82-89. [Abstract] [PDF] [References]  

Leslie Citrome

Current guidelines and their recommendations for prolactin monitoring in psychosis
J Psychopharmacol 2008 22: 90-97. [Abstract] [PDF] [References]  

Robert C Peveler, David Branford, Leslie Citrome, Peter Fitzgerald, Philip W Harvey, Richard IG Holt, Louise Howard, Dora Kohen, Ian Jones, Veronica O'Keane, Carmine M Pariente, John Pendlebury, Shubulade M Smith, and David Yeomans

Antipsychotics and hyperprolactinaemia: Clinical recommendations
J Psychopharmacol 2008 22: 98-103. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.